Skip to content

Study of Stimulus Parameters in Flicker Electroretinogram (ERG)

Study of Stimulus Parameters in Flicker Electroretinogram (ERG)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02466607
Enrollment
18
Registered
2015-06-09
Start date
2015-03-31
Completion date
2015-07-31
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy

Keywords

Retinal function

Brief summary

The electroretinogram (ERG) is a diagnostic test that measures the electrical activity generated by cells in the retina in response to a light stimulus. Typically, an ERG is recorded with white flash when the pupil is dilated. RETeval Visual Diagnostic Device (RETeval) generates an array of color flashes, which allows studying whether color flash would be a useful diagnostic tool. Full pupil dilation is required to obtain a response from the whole retina. However, this requirement often limits a patient's flow in the clinic and increases the overall time patients spend at the eye practitioner. RETeval provides the possibility of recording ERGs in un-dilated pupils therefore making the whole exam easier and shorter. These results need to be compared to the classic, fully dilated ERG and evaluated for efficiency. The purpose of this research study is to use the RETeval device to measure the eye's electrical response and how it changes with different stimuli such as changing flash color or pupil dilation.

Interventions

DEVICERETeval color flicker ERG

Flicker ERGs obtained to 56 CIE 1931 (created by the International Commission on Illumination (CIE) in 1931) colors series. White flash of 0,33, 0,33 was used for comparison.

DEVICERETeval dilated versus un-dilated flicker ERG

Two series of white flashes: 3,0 cd/m2/sec and Trolands equivalent assuming 3,7 mm pupil size, delivered at 3 min interval over 30 min.

OTHERpupil dilation

Pupil will be dilated using Proparacaine 0.5% and Tropicamide 0.5%

Sponsors

LKC Technologies, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy adult volunteers * volunteers able to get their pupil fully dilated

Exclusion criteria

* pregnant women * children * subjects with * light sensitivity * photosensitive epilepsy * allergies or sensitivity to pupil dilation ophthalmic solutions * history of glaucoma * cardiac dysrhythmia will not be invited to participate in this study. * Pregnancy status, light sensitivity and photosensitive epilepsy will be based on volunteer's providing this information at the time of signing the consent form

Design outcomes

Primary

MeasureTime frame
Flicker harmonic amplitudeup to 2 mnths
Flicker harmonic implicit timeup to 2 months
Flicker fundamental amplitudeup to 2 months
Flicker fundamental implicit timeup to 2 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026